Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FASTEST Trial: rFVIIa for Acute Hemorrhagic Stroke
NCT03496883Phase 3Active, not recruiting
- Start
- Dec 2021
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH). Started Dec 2021; status: active, not recruiting.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03496883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496883.